| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.04B | 65.16B | 64.78B | 65.83B | 66.58B | 59.08B |
| Gross Profit | 17.85B | 17.68B | 15.72B | 17.46B | 19.27B | 18.06B |
| EBITDA | 6.74B | 6.85B | 1.55B | 4.21B | 5.58B | 5.33B |
| Net Income | 2.04B | 1.78B | -2.31B | 365.00M | 1.31B | 1.17B |
Balance Sheet | ||||||
| Total Assets | 103.16B | 102.11B | 101.75B | 97.02B | 95.06B | 91.14B |
| Cash, Cash Equivalents and Short-Term Investments | 4.55B | 5.44B | 5.16B | 4.55B | 5.48B | 8.38B |
| Total Debt | 40.71B | 43.26B | 43.28B | 39.83B | 37.08B | 38.08B |
| Total Liabilities | 57.24B | 56.49B | 57.03B | 52.61B | 50.87B | 50.01B |
| Stockholders Equity | 44.98B | 44.71B | 43.86B | 43.35B | 43.15B | 40.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -440.00M | -933.00M | -3.34B | 940.00M | -960.00M |
| Operating Cash Flow | 0.00 | 3.98B | 4.03B | 109.00M | 4.60B | 4.09B |
| Investing Cash Flow | 0.00 | -3.63B | -5.07B | -2.94B | -3.92B | -5.27B |
| Financing Cash Flow | 0.00 | 71.00M | 1.53B | 1.94B | -3.80B | 2.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥10.63B | 3.04 | ― | 1.66% | 8.56% | 2690.35% | |
76 Outperform | ¥181.90B | 11.81 | ― | 4.91% | 6.35% | 14.05% | |
75 Outperform | ¥44.92B | 13.60 | ― | 2.97% | 0.89% | -14.25% | |
75 Outperform | ¥34.53B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥176.24B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
66 Neutral | ¥9.51B | 3.19 | ― | 2.65% | 1.11% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |